Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus, South Korea
暂无分享,去创建一个
Mi-Seon Kim | Hee-Bok Oh | Chun Kang | Hwajung Yi | Joo-Yeon Lee | C. Kang | W. Choi | Mi-seon Kim | Joo-Yeon Lee | Jang-Hoon Choi | Hwajung Yi | Eun-Hye Hong | Donghyok Kwon | Jang-Hoon Choi | Woo-Young Choi | Ki-Soon Kim | Jong-Koo Lee | H. Oh | D. Kwon | Ki-Soon Kim | Jong-Koo Lee | Eun-Hye Hong
[1] In Seok Yang,et al. Influenza sequence and epitope database , 2008, Nucleic Acids Res..
[2] A. Kumar,et al. Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans , 2010 .
[3] Pan Xin,et al. Novel Swine-Origin Influenza A(H1N1) Virus , 2009 .
[4] R. Webster,et al. Susceptibility of Highly Pathogenic H5N1 Influenza Viruses to the Neuraminidase Inhibitor Oseltamivir Differs In Vitro and in a Mouse Model , 2009, Antimicrobial Agents and Chemotherapy.
[5] David J. Stevens,et al. The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design , 2006, Nature.
[6] F. Hayden,et al. Assessment of hemagglutinin sequence heterogeneity during influenza virus transmission in families. , 2002, The Journal of infectious diseases.
[7] Update on oseltamivir-resistant pandemic A (H1N1) 2009 influenza virus: January 2010. , 2009, Releve epidemiologique hebdomadaire.
[8] I. Barr,et al. Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes. , 2007, Antiviral research.